Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

Congress
Main Content

Late-Breaking Abstracts

2022 Late-Breaking Abstract submission has closed


Late-breaking abstracts recognize novel, critically important research developments that occur during the lead-up to International Congress.
 

International Congress delegates look over posters of top movement disorder abstracts in the Poster Hall.

Criteria

Late-Breaking Abstracts will be considered for the 2022 International Congress if they fulfill the following criteria:

  • The topic must be of critical importance to the clinical/scientific community and/or the public.
  • The abstract must be report data that became available for public dissemination only after the deadline of the regular abstract submission (March 15, 2022), and has not been previously published or presented.
  • The study and results reported should be novel (not simply an extension of previously published work) or be definitive of confirming or refuting other critically important work.
  • The following categories are typically suited to the main poster sessions and will not be considered for Late-Breaking Abstracts: case reports, qualitative surveys, reviews of existing treatments, practice reviews, rating scale validation, small confirmatory studies, small scale epidemiology studies, research proposals.
  • The Late-Breaking Abstract program is not designed to favor investigators who inadvertently missed the deadline for regular abstract submission.
     

Late-Breaking Abstract selection strictly adheres to the criteria noted, and many high-quality abstracts are rejected on the basis of not meeting these criteria as outlined.  Historically, MDS only accepts an average of 25-30% of Late-Breaking Abstract submissions annually.

The following types of studies are NOT appropriate for the Late-Breaking Abstract program and will not be considered for acceptance: 

  • Case reports or small series of cases
  • Replication studies
  • Descriptions of study designs or plans with no presentation of data
  • Extensions of previously reported studies
  • Qualitative surveys
  • Reviews of existing treatments
  • Practice reviews
  • Rating scale validation
  • Research proposals

The Late-Breaking Abstract submission process is not intended for regular abstract submissions that inadvertently missed the 2022 deadline, and does not accept encore submissions.

 

Late-Breaking Abstract Presentations 

All accepted abstracts will be presented as an e-poster (PDF) in Madrid, as well as optional five-minute pre-recorded video presentation on the virtual platform. 

 

Late-Breaking Abstract Publication

All Late-Breaking Abstracts will be published on the MDS International Congress website.

To cite an MDS published Late-Breaking Abstract, follow this example:

[Author’s Last Name], [Author’s First and Middle Initials]. (year). International Congress of Parkinson’s Disease and Movement Disorders. Late-Breaking Abstracts, [Abstract Title], [pages].
Retrieved from https://www.mdscongress.org/About/Past-future.

Late-Breaking Abstract Archive

View the archive of International Congress Late-Breaking Abstracts:

View archive

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including mds.movementdisorders.org and mds.execinc.com. This cookie policy only covers the primary movementdisorders.org and mdscongress.org domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice